UniProt ID | HS105_HUMAN | |
---|---|---|
UniProt AC | Q92598 | |
Protein Name | Heat shock protein 105 kDa | |
Gene Name | HSPH1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 858 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Acts as a nucleotide-exchange factor (NEF) for chaperone proteins HSPA1A and HSPA1B, promoting the release of ADP from HSPA1A/B thereby triggering client/substrate protein release. [PubMed: 24318877 Prevents the aggregation of denatured proteins in cells under severe stress, on which the ATP levels decrease markedly. Inhibits HSPA8/HSC70 ATPase and chaperone activities (By similarity] | |
Protein Sequence | MSVVGLDVGSQSCYIAVARAGGIETIANEFSDRCTPSVISFGSKNRTIGVAAKNQQITHANNTVSNFKRFHGRAFNDPFIQKEKENLSYDLVPLKNGGVGIKVMYMGEEHLFSVEQITAMLLTKLKETAENSLKKPVTDCVISVPSFFTDAERRSVLDAAQIVGLNCLRLMNDMTAVALNYGIYKQDLPSLDEKPRIVVFVDMGHSAFQVSACAFNKGKLKVLGTAFDPFLGGKNFDEKLVEHFCAEFKTKYKLDAKSKIRALLRLYQECEKLKKLMSSNSTDLPLNIECFMNDKDVSGKMNRSQFEELCAELLQKIEVPLYSLLEQTHLKVEDVSAVEIVGGATRIPAVKERIAKFFGKDISTTLNADEAVARGCALQCAILSPAFKVREFSVTDAVPFPISLIWNHDSEDTEGVHEVFSRNHAAPFSKVLTFLRRGPFELEAFYSDPQGVPYPEAKIGRFVVQNVSAQKDGEKSRVKVKVRVNTHGIFTISTASMVEKVPTEENEMSSEADMECLNQRPPENPDTDKNVQQDNSEAGTQPQVQTDAQQTSQSPPSPELTSEENKIPDADKANEKKVDQPPEAKKPKIKVVNVELPIEANLVWQLGKDLLNMYIETEGKMIMQDKLEKERNDAKNAVEEYVYEFRDKLCGPYEKFICEQDHQNFLRLLTETEDWLYEEGEDQAKQAYVDKLEELMKIGTPVKVRFQEAEERPKMFEELGQRLQHYAKIAADFRNKDEKYNHIDESEMKKVEKSVNEVMEWMNNVMNAQAKKSLDQDPVVRAQEIKTKIKELNNTCEPVVTQPKPKIESPKLERTPNGPNIDKKEEDLEDKNNFGAEPPHQNGECYPNEKNSVNMDLD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSVVGLDVG ------CCEEEEECC | 26.05 | 22223895 | |
2 | Phosphorylation | ------MSVVGLDVG ------CCEEEEECC | 26.05 | 24043423 | |
10 | Phosphorylation | VVGLDVGSQSCYIAV EEEEECCCCEEEEEH | 20.83 | 22817900 | |
12 | Phosphorylation | GLDVGSQSCYIAVAR EEECCCCEEEEEHHH | 15.58 | 22817900 | |
14 | Phosphorylation | DVGSQSCYIAVARAG ECCCCEEEEEHHHCC | 9.36 | 22817900 | |
25 | Phosphorylation | ARAGGIETIANEFSD HHCCCHHHHHHHCCC | 24.38 | - | |
31 | Phosphorylation | ETIANEFSDRCTPSV HHHHHHCCCCCCCCE | 20.26 | 22817900 | |
33 | Methylation | IANEFSDRCTPSVIS HHHHCCCCCCCCEEE | 25.63 | 115479691 | |
34 | S-palmitoylation | ANEFSDRCTPSVISF HHHCCCCCCCCEEEE | 8.67 | 26865113 | |
37 | Phosphorylation | FSDRCTPSVISFGSK CCCCCCCCEEEECCC | 17.58 | 28450419 | |
40 | Phosphorylation | RCTPSVISFGSKNRT CCCCCEEEECCCCCE | 22.77 | 28450419 | |
43 | Phosphorylation | PSVISFGSKNRTIGV CCEEEECCCCCEEEE | 25.42 | 28450419 | |
44 | Ubiquitination | SVISFGSKNRTIGVA CEEEECCCCCEEEEE | 51.32 | - | |
53 | 2-Hydroxyisobutyrylation | RTIGVAAKNQQITHA CEEEEEEECCEEECC | 45.62 | - | |
53 | Ubiquitination | RTIGVAAKNQQITHA CEEEEEEECCEEECC | 45.62 | 21890473 | |
53 (in isoform 2) | Ubiquitination | - | 45.62 | 22053931 | |
53 (in isoform 3) | Ubiquitination | - | 45.62 | 21906983 | |
55 (in isoform 1) | Ubiquitination | - | 35.03 | 21906983 | |
68 | 2-Hydroxyisobutyrylation | NNTVSNFKRFHGRAF CCCCCHHHHHCCCCC | 59.41 | - | |
68 | Acetylation | NNTVSNFKRFHGRAF CCCCCHHHHHCCCCC | 59.41 | 25953088 | |
68 | Methylation | NNTVSNFKRFHGRAF CCCCCHHHHHCCCCC | 59.41 | 129939 | |
68 | Ubiquitination | NNTVSNFKRFHGRAF CCCCCHHHHHCCCCC | 59.41 | 21906983 | |
68 (in isoform 2) | Ubiquitination | - | 59.41 | 22053931 | |
68 (in isoform 3) | Ubiquitination | - | 59.41 | 21906983 | |
70 | Ubiquitination | TVSNFKRFHGRAFND CCCHHHHHCCCCCCC | 8.05 | - | |
70 (in isoform 1) | Ubiquitination | - | 8.05 | 21906983 | |
82 | Acetylation | FNDPFIQKEKENLSY CCCHHHHHHHCCCCC | 66.97 | 27452117 | |
82 | Ubiquitination | FNDPFIQKEKENLSY CCCHHHHHHHCCCCC | 66.97 | - | |
82 (in isoform 2) | Ubiquitination | - | 66.97 | - | |
84 | Ubiquitination | DPFIQKEKENLSYDL CHHHHHHHCCCCCCE | 59.96 | - | |
84 | 2-Hydroxyisobutyrylation | DPFIQKEKENLSYDL CHHHHHHHCCCCCCE | 59.96 | - | |
84 | Acetylation | DPFIQKEKENLSYDL CHHHHHHHCCCCCCE | 59.96 | 25953088 | |
84 | Ubiquitination | DPFIQKEKENLSYDL CHHHHHHHCCCCCCE | 59.96 | - | |
86 | Ubiquitination | FIQKEKENLSYDLVP HHHHHHCCCCCCEEE | 45.41 | - | |
89 | Phosphorylation | KEKENLSYDLVPLKN HHHCCCCCCEEECCC | 19.23 | 22817900 | |
95 | Acetylation | SYDLVPLKNGGVGIK CCCEEECCCCCEEEE | 47.69 | 25953088 | |
95 | Ubiquitination | SYDLVPLKNGGVGIK CCCEEECCCCCEEEE | 47.69 | 21906983 | |
95 (in isoform 2) | Ubiquitination | - | 47.69 | 22053931 | |
95 (in isoform 3) | Ubiquitination | - | 47.69 | 21906983 | |
97 (in isoform 1) | Ubiquitination | - | 30.49 | 21906983 | |
102 | Ubiquitination | KNGGVGIKVMYMGEE CCCCEEEEEEECCCC | 18.28 | - | |
104 | Ubiquitination | GGVGIKVMYMGEEHL CCEEEEEEECCCCCC | 1.29 | - | |
105 | Phosphorylation | GVGIKVMYMGEEHLF CEEEEEEECCCCCCC | 12.64 | 20860994 | |
126 | Ubiquitination | AMLLTKLKETAENSL HHHHHHHHHHHHHHC | 55.35 | - | |
132 | Phosphorylation | LKETAENSLKKPVTD HHHHHHHHCCCCCCC | 32.83 | - | |
138 | Phosphorylation | NSLKKPVTDCVISVP HHCCCCCCCEEEECC | 32.01 | - | |
149 | Phosphorylation | ISVPSFFTDAERRSV EECCCCCCHHHHHHH | 32.08 | 27251275 | |
167 | Glutathionylation | AQIVGLNCLRLMNDM HHHHCHHHHHHHCHH | 2.55 | 22555962 | |
180 (in isoform 3) | Ubiquitination | - | 24.21 | 21906983 | |
185 | Ubiquitination | ALNYGIYKQDLPSLD HHHCCHHHCCCCCCC | 35.10 | - | |
187 | Ubiquitination | NYGIYKQDLPSLDEK HCCHHHCCCCCCCCC | 57.29 | - | |
193 (in isoform 3) | Ubiquitination | - | 70.97 | 21906983 | |
194 | Acetylation | DLPSLDEKPRIVVFV CCCCCCCCCCEEEEE | 38.98 | 23749302 | |
194 | Ubiquitination | DLPSLDEKPRIVVFV CCCCCCCCCCEEEEE | 38.98 | 22053931 | |
194 (in isoform 2) | Ubiquitination | - | 38.98 | 22053931 | |
196 | Acetylation | PSLDEKPRIVVFVDM CCCCCCCCEEEEEEC | 45.46 | - | |
196 | Ubiquitination | PSLDEKPRIVVFVDM CCCCCCCCEEEEEEC | 45.46 | - | |
221 | Ubiquitination | AFNKGKLKVLGTAFD CCCCCCEEEEEEECC | 38.61 | 21906983 | |
221 (in isoform 2) | Ubiquitination | - | 38.61 | 22053931 | |
223 | Ubiquitination | NKGKLKVLGTAFDPF CCCCEEEEEEECCHH | 4.89 | - | |
223 (in isoform 1) | Ubiquitination | - | 4.89 | 21906983 | |
225 | Phosphorylation | GKLKVLGTAFDPFLG CCEEEEEEECCHHCC | 21.71 | 21601212 | |
234 | 2-Hydroxyisobutyrylation | FDPFLGGKNFDEKLV CCHHCCCCCCCHHHH | 53.28 | - | |
234 | Acetylation | FDPFLGGKNFDEKLV CCHHCCCCCCCHHHH | 53.28 | 132957 | |
234 | Ubiquitination | FDPFLGGKNFDEKLV CCHHCCCCCCCHHHH | 53.28 | 21906983 | |
234 (in isoform 2) | Ubiquitination | - | 53.28 | 22053931 | |
236 | Ubiquitination | PFLGGKNFDEKLVEH HHCCCCCCCHHHHHH | 17.07 | - | |
236 (in isoform 1) | Ubiquitination | - | 17.07 | 21906983 | |
239 | Ubiquitination | GGKNFDEKLVEHFCA CCCCCCHHHHHHHHH | 60.73 | - | |
249 | Acetylation | EHFCAEFKTKYKLDA HHHHHHHCHHCCCCH | 35.30 | 25953088 | |
249 | Ubiquitination | EHFCAEFKTKYKLDA HHHHHHHCHHCCCCH | 35.30 | - | |
257 | Acetylation | TKYKLDAKSKIRALL HHCCCCHHHHHHHHH | 52.53 | 25953088 | |
265 | Methylation | SKIRALLRLYQECEK HHHHHHHHHHHHHHH | 32.00 | - | |
272 | Acetylation | RLYQECEKLKKLMSS HHHHHHHHHHHHHHC | 76.81 | 23749302 | |
272 | Ubiquitination | RLYQECEKLKKLMSS HHHHHHHHHHHHHHC | 76.81 | 19608861 | |
274 | Acetylation | YQECEKLKKLMSSNS HHHHHHHHHHHHCCC | 55.73 | 7987869 | |
274 | Ubiquitination | YQECEKLKKLMSSNS HHHHHHHHHHHHCCC | 55.73 | - | |
275 | Ubiquitination | QECEKLKKLMSSNST HHHHHHHHHHHCCCC | 60.91 | - | |
278 | Phosphorylation | EKLKKLMSSNSTDLP HHHHHHHHCCCCCCC | 36.48 | 30624053 | |
279 | Phosphorylation | KLKKLMSSNSTDLPL HHHHHHHCCCCCCCC | 22.34 | 30624053 | |
281 | Phosphorylation | KKLMSSNSTDLPLNI HHHHHCCCCCCCCEE | 25.83 | 30624053 | |
290 | Glutathionylation | DLPLNIECFMNDKDV CCCCEEEEECCCCCC | 3.29 | 22555962 | |
295 | Acetylation | IECFMNDKDVSGKMN EEEECCCCCCCCCCC | 55.83 | 25953088 | |
295 | Ubiquitination | IECFMNDKDVSGKMN EEEECCCCCCCCCCC | 55.83 | - | |
298 | O-linked_Glycosylation | FMNDKDVSGKMNRSQ ECCCCCCCCCCCHHH | 42.71 | 23301498 | |
300 | Ubiquitination | NDKDVSGKMNRSQFE CCCCCCCCCCHHHHH | 26.04 | - | |
304 | O-linked_Glycosylation | VSGKMNRSQFEELCA CCCCCCHHHHHHHHH | 33.93 | 23301498 | |
304 | Phosphorylation | VSGKMNRSQFEELCA CCCCCCHHHHHHHHH | 33.93 | 21712546 | |
310 | Glutathionylation | RSQFEELCAELLQKI HHHHHHHHHHHHHHC | 2.90 | 22555962 | |
322 | Phosphorylation | QKIEVPLYSLLEQTH HHCCCCHHHHHHHCC | 7.39 | - | |
345 | Phosphorylation | VEIVGGATRIPAVKE EEEECCCCCCHHHHH | 32.19 | 20860994 | |
347 (in isoform 3) | Ubiquitination | - | 1.92 | 21906983 | |
351 | 2-Hydroxyisobutyrylation | ATRIPAVKERIAKFF CCCCHHHHHHHHHHH | 43.30 | - | |
351 | Ubiquitination | ATRIPAVKERIAKFF CCCCHHHHHHHHHHH | 43.30 | - | |
356 | 2-Hydroxyisobutyrylation | AVKERIAKFFGKDIS HHHHHHHHHHCCCHH | 38.56 | - | |
356 | Acetylation | AVKERIAKFFGKDIS HHHHHHHHHHCCCHH | 38.56 | 25953088 | |
356 | Ubiquitination | AVKERIAKFFGKDIS HHHHHHHHHHCCCHH | 38.56 | - | |
360 | Acetylation | RIAKFFGKDISTTLN HHHHHHCCCHHHCCC | 46.89 | 26051181 | |
360 | Ubiquitination | RIAKFFGKDISTTLN HHHHHHCCCHHHCCC | 46.89 | - | |
365 | Phosphorylation | FGKDISTTLNADEAV HCCCHHHCCCHHHHH | 15.95 | - | |
376 | Glutathionylation | DEAVARGCALQCAIL HHHHHHHHHHHHHHH | 2.59 | 22555962 | |
376 | S-palmitoylation | DEAVARGCALQCAIL HHHHHHHHHHHHHHH | 2.59 | 29575903 | |
380 | S-palmitoylation | ARGCALQCAILSPAF HHHHHHHHHHHCCCE | 2.37 | 29575903 | |
384 | Phosphorylation | ALQCAILSPAFKVRE HHHHHHHCCCEEEEE | 14.20 | 25159151 | |
388 | Methylation | AILSPAFKVREFSVT HHHCCCEEEEEEECC | 42.35 | 7869883 | |
388 | Ubiquitination | AILSPAFKVREFSVT HHHCCCEEEEEEECC | 42.35 | 22053931 | |
388 (in isoform 2) | Ubiquitination | - | 42.35 | 22053931 | |
389 (in isoform 3) | Ubiquitination | - | 5.99 | 21906983 | |
390 | Ubiquitination | LSPAFKVREFSVTDA HCCCEEEEEEECCCC | 39.57 | - | |
390 (in isoform 1) | Ubiquitination | - | 39.57 | 21906983 | |
417 (in isoform 3) | Ubiquitination | - | 36.04 | 21906983 | |
429 | Phosphorylation | RNHAAPFSKVLTFLR CCCCCCHHHHHHHHH | 22.31 | 25849741 | |
430 | Acetylation | NHAAPFSKVLTFLRR CCCCCHHHHHHHHHH | 41.46 | 19608861 | |
430 | Ubiquitination | NHAAPFSKVLTFLRR CCCCCHHHHHHHHHH | 41.46 | 19608861 | |
430 (in isoform 2) | Ubiquitination | - | 41.46 | 22053931 | |
430 (in isoform 3) | Ubiquitination | - | 41.46 | 21906983 | |
432 | Acetylation | AAPFSKVLTFLRRGP CCCHHHHHHHHHHCC | 3.01 | 19608861 | |
432 | Ubiquitination | AAPFSKVLTFLRRGP CCCHHHHHHHHHHCC | 3.01 | 19608861 | |
432 (in isoform 1) | Ubiquitination | - | 3.01 | 21906983 | |
433 | Phosphorylation | APFSKVLTFLRRGPF CCHHHHHHHHHHCCE | 24.50 | 23312004 | |
446 | Phosphorylation | PFELEAFYSDPQGVP CEEEEEEEECCCCCC | 21.15 | - | |
458 | Ubiquitination | GVPYPEAKIGRFVVQ CCCCCHHHHCCEEEE | 43.99 | 22053931 | |
458 (in isoform 2) | Ubiquitination | - | 43.99 | 22053931 | |
460 (in isoform 1) | Ubiquitination | - | 19.10 | 21906983 | |
468 | Phosphorylation | RFVVQNVSAQKDGEK CEEEEECCCCCCCCC | 32.31 | 27050516 | |
471 | 2-Hydroxyisobutyrylation | VQNVSAQKDGEKSRV EEECCCCCCCCCCCE | 68.37 | - | |
471 | Acetylation | VQNVSAQKDGEKSRV EEECCCCCCCCCCCE | 68.37 | 23236377 | |
471 | Malonylation | VQNVSAQKDGEKSRV EEECCCCCCCCCCCE | 68.37 | 26320211 | |
471 | Ubiquitination | VQNVSAQKDGEKSRV EEECCCCCCCCCCCE | 68.37 | - | |
471 (in isoform 2) | Ubiquitination | - | 68.37 | 22053931 | |
473 (in isoform 1) | Ubiquitination | - | 51.79 | 21906983 | |
475 | Ubiquitination | SAQKDGEKSRVKVKV CCCCCCCCCCEEEEE | 49.44 | - | |
486 | Phosphorylation | KVKVRVNTHGIFTIS EEEEEECCCCEEEEE | 20.72 | 27273156 | |
491 | Phosphorylation | VNTHGIFTISTASMV ECCCCEEEEEEHHHE | 16.46 | 27080861 | |
493 | Phosphorylation | THGIFTISTASMVEK CCCEEEEEEHHHEEE | 18.18 | 23312004 | |
494 | Phosphorylation | HGIFTISTASMVEKV CCEEEEEEHHHEEEC | 20.92 | 25693802 | |
496 | Phosphorylation | IFTISTASMVEKVPT EEEEEEHHHEEECCC | 24.37 | 27080861 | |
503 | Phosphorylation | SMVEKVPTEENEMSS HHEEECCCCCCCCCC | 59.94 | 28450419 | |
509 | Phosphorylation | PTEENEMSSEADMEC CCCCCCCCCHHHHHH | 20.88 | 28450419 | |
510 | Phosphorylation | TEENEMSSEADMECL CCCCCCCCHHHHHHH | 35.18 | 30576142 | |
527 | Phosphorylation | RPPENPDTDKNVQQD CCCCCCCCCCCCCCC | 50.56 | 26074081 | |
536 | Phosphorylation | KNVQQDNSEAGTQPQ CCCCCCCCCCCCCCC | 36.79 | 20068231 | |
540 | Phosphorylation | QDNSEAGTQPQVQTD CCCCCCCCCCCCCCC | 44.09 | 29496963 | |
546 | Phosphorylation | GTQPQVQTDAQQTSQ CCCCCCCCCHHHHCC | 34.15 | 30278072 | |
551 | Phosphorylation | VQTDAQQTSQSPPSP CCCCHHHHCCCCCCC | 19.36 | 25159151 | |
552 | Phosphorylation | QTDAQQTSQSPPSPE CCCHHHHCCCCCCCC | 25.07 | 25159151 | |
554 | Phosphorylation | DAQQTSQSPPSPELT CHHHHCCCCCCCCCC | 38.25 | 30278072 | |
557 | Phosphorylation | QTSQSPPSPELTSEE HHCCCCCCCCCCCCC | 34.10 | 25159151 | |
561 | Phosphorylation | SPPSPELTSEENKIP CCCCCCCCCCCCCCC | 32.22 | 20201521 | |
562 | Phosphorylation | PPSPELTSEENKIPD CCCCCCCCCCCCCCC | 56.38 | 30278072 | |
582 (in isoform 2) | Ubiquitination | - | 48.85 | 22053931 | |
585 (in isoform 3) | Ubiquitination | - | 68.87 | 21906983 | |
588 | Ubiquitination | PPEAKKPKIKVVNVE CCCCCCCCEEEEEEE | 65.13 | - | |
590 | Ubiquitination | EAKKPKIKVVNVELP CCCCCCEEEEEEECC | 46.38 | - | |
611 (in isoform 2) | Ubiquitination | - | 5.06 | 22053931 | |
613 | Sulfoxidation | LGKDLLNMYIETEGK HCHHHHHHHHHHCCC | 3.44 | 28183972 | |
614 | Phosphorylation | GKDLLNMYIETEGKM CHHHHHHHHHHCCCH | 8.43 | - | |
626 | Ubiquitination | GKMIMQDKLEKERND CCHHHHHHHHHHHHH | 41.47 | - | |
628 (in isoform 1) | Ubiquitination | - | 59.62 | 21906983 | |
635 | Ubiquitination | EKERNDAKNAVEEYV HHHHHHHHHHHHHHH | 48.59 | - | |
641 | Phosphorylation | AKNAVEEYVYEFRDK HHHHHHHHHHHHHHH | 8.53 | 28152594 | |
643 | Phosphorylation | NAVEEYVYEFRDKLC HHHHHHHHHHHHHHC | 14.40 | 28152594 | |
648 | Acetylation | YVYEFRDKLCGPYEK HHHHHHHHHCCCHHH | 41.23 | 25953088 | |
648 | Ubiquitination | YVYEFRDKLCGPYEK HHHHHHHHHCCCHHH | 41.23 | - | |
653 | Phosphorylation | RDKLCGPYEKFICEQ HHHHCCCHHHCEECH | 19.62 | 28152594 | |
655 | 2-Hydroxyisobutyrylation | KLCGPYEKFICEQDH HHCCCHHHCEECHHH | 33.90 | - | |
655 | Acetylation | KLCGPYEKFICEQDH HHCCCHHHCEECHHH | 33.90 | 25953088 | |
655 | Ubiquitination | KLCGPYEKFICEQDH HHCCCHHHCEECHHH | 33.90 | 22053931 | |
657 | Ubiquitination | CGPYEKFICEQDHQN CCCHHHCEECHHHHH | 3.61 | - | |
659 (in isoform 2) | Ubiquitination | - | 54.98 | - | |
670 | Phosphorylation | QNFLRLLTETEDWLY HHHHHHHHHCHHHHH | 45.51 | - | |
672 | Phosphorylation | FLRLLTETEDWLYEE HHHHHHHCHHHHHHC | 33.73 | - | |
677 | Phosphorylation | TETEDWLYEEGEDQA HHCHHHHHHCCHHHH | 14.00 | 27259358 | |
688 | Phosphorylation | EDQAKQAYVDKLEEL HHHHHHHHHHHHHHH | 13.49 | - | |
691 | 2-Hydroxyisobutyrylation | AKQAYVDKLEELMKI HHHHHHHHHHHHHHH | 47.99 | - | |
691 | Acetylation | AKQAYVDKLEELMKI HHHHHHHHHHHHHHH | 47.99 | 23236377 | |
691 | Ubiquitination | AKQAYVDKLEELMKI HHHHHHHHHHHHHHH | 47.99 | 21890473 | |
697 | 2-Hydroxyisobutyrylation | DKLEELMKIGTPVKV HHHHHHHHHCCCEEE | 51.08 | - | |
697 | Ubiquitination | DKLEELMKIGTPVKV HHHHHHHHHCCCEEE | 51.08 | - | |
699 | Ubiquitination | LEELMKIGTPVKVRF HHHHHHHCCCEEEEC | 20.60 | - | |
700 | Phosphorylation | EELMKIGTPVKVRFQ HHHHHHCCCEEEECH | 28.51 | 27134283 | |
703 | 2-Hydroxyisobutyrylation | MKIGTPVKVRFQEAE HHHCCCEEEECHHHH | 28.97 | - | |
703 | Acetylation | MKIGTPVKVRFQEAE HHHCCCEEEECHHHH | 28.97 | 25953088 | |
703 | Ubiquitination | MKIGTPVKVRFQEAE HHHCCCEEEECHHHH | 28.97 | - | |
714 | Ubiquitination | QEAEERPKMFEELGQ HHHHHCHHHHHHHHH | 63.54 | - | |
728 | Acetylation | QRLQHYAKIAADFRN HHHHHHHHHHHHHCC | 26.22 | 25953088 | |
739 | 2-Hydroxyisobutyrylation | DFRNKDEKYNHIDES HHCCCCHHCCCCCHH | 62.58 | - | |
740 | Phosphorylation | FRNKDEKYNHIDESE HCCCCHHCCCCCHHH | 15.21 | 28509920 | |
749 | Acetylation | HIDESEMKKVEKSVN CCCHHHHHHHHHHHH | 50.01 | 25953088 | |
749 | Ubiquitination | HIDESEMKKVEKSVN CCCHHHHHHHHHHHH | 50.01 | - | |
750 | Acetylation | IDESEMKKVEKSVNE CCHHHHHHHHHHHHH | 55.08 | 25953088 | |
753 | Ubiquitination | SEMKKVEKSVNEVME HHHHHHHHHHHHHHH | 63.79 | - | |
771 | Acetylation | NVMNAQAKKSLDQDP HHHHHHHHHHCCCCH | 30.71 | 25953088 | |
772 | Ubiquitination | VMNAQAKKSLDQDPV HHHHHHHHHCCCCHH | 60.30 | - | |
790 | Acetylation | QEIKTKIKELNNTCE HHHHHHHHHHCCCCC | 58.67 | 26051181 | |
790 | Ubiquitination | QEIKTKIKELNNTCE HHHHHHHHHHCCCCC | 58.67 | 2189047 | |
795 | Phosphorylation | KIKELNNTCEPVVTQ HHHHHCCCCCCCCCC | 19.71 | 26074081 | |
796 | Glutathionylation | IKELNNTCEPVVTQP HHHHCCCCCCCCCCC | 6.38 | 22555962 | |
801 | Phosphorylation | NTCEPVVTQPKPKIE CCCCCCCCCCCCCCC | 39.11 | 26074081 | |
804 | Ubiquitination | EPVVTQPKPKIESPK CCCCCCCCCCCCCCC | 49.47 | - | |
806 | Ubiquitination | VVTQPKPKIESPKLE CCCCCCCCCCCCCCC | 66.29 | - | |
809 | Phosphorylation | QPKPKIESPKLERTP CCCCCCCCCCCCCCC | 30.70 | 29255136 | |
811 | Acetylation | KPKIESPKLERTPNG CCCCCCCCCCCCCCC | 72.72 | 83037497 | |
811 | Ubiquitination | KPKIESPKLERTPNG CCCCCCCCCCCCCCC | 72.72 | - | |
815 | Phosphorylation | ESPKLERTPNGPNID CCCCCCCCCCCCCCC | 16.25 | 30266825 | |
823 | Acetylation | PNGPNIDKKEEDLED CCCCCCCCCHHHCCC | 59.28 | 27452117 | |
823 | Ubiquitination | PNGPNIDKKEEDLED CCCCCCCCCHHHCCC | 59.28 | - | |
824 | Ubiquitination | NGPNIDKKEEDLEDK CCCCCCCCHHHCCCC | 63.69 | - | |
846 | Phosphorylation | PHQNGECYPNEKNSV CCCCCCCCCCCCCCC | 12.56 | 28555341 | |
850 | Acetylation | GECYPNEKNSVNMDL CCCCCCCCCCCCCCC | 62.25 | 26051181 | |
852 | Phosphorylation | CYPNEKNSVNMDLD- CCCCCCCCCCCCCC- | 26.41 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HS105_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
509 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HS105_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-430, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557 AND SER-562, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-700; SER-809 ANDTHR-815, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-809, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557 AND SER-809, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384 AND THR-815, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND MASSSPECTROMETRY. |